Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Immune Checkpoint Inhibitors × Clear all

NCT03943472 2021-08-31

BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Unknown

Multiple Myeloma